Unlocking Data for Profitable Clinical Development: Interview with: Staffan Gestrelius, President and Chief Executive Officer & Jerker Ringstrom, Head of Business Development, Capish, a solution provider at the marcus evans Evolution Summit 2012 in North America and Evolution Summit 2012 in Europe, on unlocking the data of clinical trials for more profitable clinical development.

1. Unlocking Data
for Profitable
Clinical Development
Staffan Gestrelius: Scientists need to then all of a sudden you have to focus
probe and analyze data the way the on the patient and what genetic
financial sector does. To make better patterns or biomarkers he reacts to, this
decisions and learn more about their will be an important turning point in
compounds and patients, they must drug development.
unlock data throughout the study and
not just at the end. This will become
even more important with personalized
medicine.
How can clinical data become a
Knowledge
knowledge asset?
directly impacts
Jerker Ringstrom: One of the most
important words in this space is profitability
“knowledge”. To turn data into a
knowledge asset, it must be put into
perspective. Scientists need constant
feedback when deciding whether to Can it help scientists be more
continue with a program or to make innovative? How?
amendments.
Jerker Ringstrom: Scientists can get
If you look at a clinical trial protocol, it new ideas for indications by better
usually mirrors the situation of the analyzing data. More drugs today are
study six to eight months before it being used in new formulations and for
ended. This means there was time to new indications, but finding these new
Interview with: Staffan Gestrelius, make valuable changes to the design indications is proving to be challenging.
President and Chief Executive and improve the quality of the trial.
Officer & Jerker Ringstrom, Head of How is this approach more
Business Development, Capish How could this enhance safety? profitable?
Staffan Gestrelius: If you have a system Staffan Gestrelius: This will be a
Scientists must unlock and analyze data that continuously watches over patients knowledge game. It will become crucial
throughout the clinical trial, according and gives you access to graphs and to know everything about a specific
to Staffan Gestrelius, President and statistics, you can keep track of adverse drug. This approach is more profitable
Chief Executive Officer and Jerker events and drug associated adverse because people are not willing to pay for
Ringstrom, Head of Business effects. The earlier this is done, the a drug that only has a 50 per cent
Development, Capish. From a solution better. chance of curing them. The reason why
provider company at the marcus evans many companies are troubled today is
Evolution Summit 2012, in North Jerker Ringstrom: This also helps because they do not have good enough
America and the Evolution Summit pharmaceutical companies be patient treatments.
2012 in Europe, Gestrelius and centric. When you develop a new drug,
Ringstrom discuss how knowledge you need to come up with a diagnostic Knowledge directly impacts profitability.
directly impacts the profitability of tool. The patient plays a more central Pharmaceutical companies should focus
clinical development. role than before, as the diagnosis will be more on knowledge than on showing
the torch through the darkness. I that the drug is not dangerous, simply
What role can Business Intelligence emphasize darkness, because when you to get it approved by the FDA. This will
tools play in clinical development? focus on means and standard deviations not be enough.

2. For more information please send an email to info@marcusevanscy.com or visit
The Pharma Network - the event websites below:
marcus evans Summits group
delivers peer-to-peer information Evolution Summit 2012 - North America: www.evolutionsummit.com
on strategic matters, professional
trends and breakthrough Evolution Summit 2012 - Europe: www.evolution-summit.com
innovations.
Contact
Please note that the Summit is a Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits
closed business event and the Division
number of participants strictly
Tel: + 357 22 849 313
limited.
Email: press@marcusevanscy.com
All rights reserved. The above content may be republished or reproduced. Kindly
inform us by sending an email to press@marcusevanscy.com
About Capish
Capish is a Swedish Knowledge Management Service Organisation founded in 2001. We can give non-data literate experts
immediate access to all clinical and non-clinical information through easy-to-use web-based interactive graphical interfaces for
searching and also interactive statistical tools for analyses. Capish will shortly be available for prospective trials.
www.capishknowledge.com
About marcus evans Summits
marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss
strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to
individually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings.
For more information, please visit: www.marcusevans.com
Upcoming Events
Discovery Summit (Europe) - www.discovery-summit.com
Discovery Summit (North America) - www.thediscoverysummit.com
Evolution Summit (Europe) - www.evolution-summit.com
Evolution Summit (North America) - www.evolutionsummit.com
To view the web version of this interview please click here:
www.pharmaceuticalseries.com/StaffanGestreliusJerkerRingstrom